Amylyx Prices Newly Approved ALS Drug at $12,500 a Month
The drug, called Relyvrio, was approved by the Food and Drug Administration late Thursday after some staff had raised questions...
Biohaven Pharmaceutical Holding
MORNING TOP NEWS AND BLOG
